Literature DB >> 15760096

Regional permeability of salmon calcitonin in isolated rat gastrointestinal tracts: transport mechanism using Caco-2 cell monolayer.

Rakhi B Shah1, Mansoor A Khan.   

Abstract

The objective of the study was to determine the region of maximum permeation of salmon calcitonin (sCT) through the gastrointestinal tract and to investigate the mechanism of permeation. For regional permeability determination, male Sprague-Dawley rats (250-300 g) were anesthetized and the gastrointestinal tissues were isolated. Stomach, duodenum, jejunum, ileum, or colon tissues were mounted on Navicyte side-by-side diffusion apparatus. Salmon calcitonin solutions (50 microm in phosphate-buffered saline, pH 7.4, 37 degrees C) were added to the donor side, and the samples were removed from the receiver compartment and analyzed by competitive radioimmunoassay (RIA). For mechanistic studies, Caco-2 cells were grown on Transwell inserts (0.4-microm pore size, 0.33 cm2 area) in a humidified 37 degrees C incubator (with 5% CO2). Transport experiments were conducted for sCT solutions (50 microm in Dulbecco's modified eagle's medium [DMEM], pH 7.4) from the apical-to-basolateral (A-to-B) direction and B-to-A direction at 37 degrees C and from the A-to-B direction at 4 degrees C. Cell monolayer integrity was monitored by mannitol permeability and transepithelial electrical resistance (TEER) measurements. The permeability coefficients (x 10(-9), cm/sec) for sCT through rat stomach, duodenum, jejunum, ileum, and colon tissues were 0.482 +/- 0.086, 0.718 +/- 0.025, 0.830 +/- 0.053, 1.537 +/- 0.32, and 0.934 +/- 0.15, respectively. The region of maximum sCT permeability is ileum followed by colon, jejunum, duodenum, and stomach. The permeability coefficients (x 10(-6), cm/sec) for sCT through Caco-2 cell monolayer were 8.57 +/- 2.34 (A-to-B, 37 degrees C), 8.01 +/- 1.22 (A-to-B, 4 degrees C), and 6.15 +/- 1.97 (B-to-A, 37 degrees C). The mechanism of its permeation is passive diffusion through the mucosa as determined from the Caco-2 monolayer permeability of sCT.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15760096      PMCID: PMC2751227          DOI: 10.1208/aapsj060431

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  13 in total

Review 1.  Delivery systems for penetration enhancement of peptide and protein drugs: design considerations.

Authors:  U B Kompella; V H Lee
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

2.  Protection of salmon calcitonin breakdown with serine proteases by various ovomucoid species for oral drug delivery.

Authors:  Rakhi B Shah; Mansoor A Khan
Journal:  J Pharm Sci       Date:  2004-02       Impact factor: 3.534

3.  A novel calcitonin receptor gene in human osteoclasts from normal bone marrow.

Authors:  T Nishikawa; H Ishikawa; S Yamamoto; Y Koshihara
Journal:  FEBS Lett       Date:  1999-09-24       Impact factor: 4.124

4.  Utility of pharmacodynamic measures for assessing the oral bioavailability of peptides. 1. Administration of recombinant salmon calcitonin in rats.

Authors:  P J Sinko; C L Smith; L T McWhorter; W Stern; E Wagner; J P Gilligan
Journal:  J Pharm Sci       Date:  1995-11       Impact factor: 3.534

5.  Quantitative determination of macromolecular transport rate across intestinal Peyer's patches.

Authors:  D J Keljo; J R Hamilton
Journal:  Am J Physiol       Date:  1983-06

6.  Expression of calcitonin gene-related peptide receptor components, calcitonin receptor-like receptor and receptor activity modifying protein 1, in the rat placenta during pregnancy and their cellular localization.

Authors:  Y L Dong; S Vegiraju; M Chauhan; C Yallampalli
Journal:  Mol Hum Reprod       Date:  2003-08       Impact factor: 4.025

7.  Colonic absorption of human calcitonin in man.

Authors:  K H Antonin; V Saano; P Bieck; J Hastewell; R Fox; P Lowe; M Mackay
Journal:  Clin Sci (Lond)       Date:  1992-11       Impact factor: 6.124

8.  Intracolonic bioavailability of human calcitonin in man.

Authors:  C Beglinger; W Born; R Muff; J Drewe; J L Dreyfuss; A Bock; M Mackay; J A Fischer
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

9.  Absorption of human calcitonin across the rat colon in vivo.

Authors:  J Hastewell; S Lynch; I Williamson; R Fox; M Mackay
Journal:  Clin Sci (Lond)       Date:  1992-05       Impact factor: 6.124

10.  Absorption characteristics of chemically modified-insulin derivatives with various fatty acids in the small and large intestine.

Authors:  H Asada; T Douen; M Waki; S Adachi; T Fujita; A Yamamoto; S Muranishi
Journal:  J Pharm Sci       Date:  1995-06       Impact factor: 3.534

View more
  4 in total

1.  Preparation and characterization of salmon calcitonin-biotin conjugates.

Authors:  Meltem Cetin; Yu Seok Youn; Yilmaz Capan; Kang Choon Lee
Journal:  AAPS PharmSciTech       Date:  2008-12-11       Impact factor: 3.246

2.  Evaluation of the Oral Bioavailability of Low Molecular Weight Heparin Formulated With Glycyrrhetinic Acid as Permeation Enhancer.

Authors:  Nusrat A Motlekar; Kalkunte S Srivenugopal; Mitchell S Wachtel; Bi-Botti C Youan
Journal:  Drug Dev Res       Date:  2006-02       Impact factor: 4.360

3.  Permeation of insulin, calcitonin and exenatide across Caco-2 monolayers: measurement using a rapid, 3-day system.

Authors:  Vivek Gupta; Nishit Doshi; Samir Mitragotri
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

4.  Prolonged hypocalcemic effect by pulmonary delivery of calcitonin loaded poly(methyl vinyl ether maleic acid) bioadhesive nanoparticles.

Authors:  J Varshosaz; M Minaiyan; M Forghanian
Journal:  Biomed Res Int       Date:  2014-02-20       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.